drugset / Trial / NCT04551066
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.
Timeline
- Start
- 2021-05-24
- Primary completion
- 2023-08-03
- Completion
- 2024-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parsaclisib | Small molecule | — | Oral |
| Background | Ruxolitinib | Small molecule | — | Oral |